Status:
COMPLETED
Efficacy and Safety of NVP-1203 in Patients With Acute Low Back Pain
Lead Sponsor:
NVP Healthcare
Conditions:
Acute Low Back Pain
Eligibility:
All Genders
19+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the efficacy and safety NVP-1203 in patients with Acute low back pain
Detailed Description
This study is a randomized, double-blind, active- and placebo-controlled, parallel, phase II study to evaluate efficacy and safety of NVP-1203 in patients with Acute low back pain
Eligibility Criteria
Inclusion
- Subjects who have ability to comprehend the contents of study and before participating in trial and have willingness to sign of informed consent in writing
- 19 Years and older
- A patient has symptom of acute low back pain
Exclusion
- Subjects who cannot prohibit anti-inflammatory drug or muscle relaxants during clinical trial
- Inadequate subject for the clinical trial by the investigator's decision
Key Trial Info
Start Date :
January 31 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 15 2019
Estimated Enrollment :
91 Patients enrolled
Trial Details
Trial ID
NCT03341832
Start Date
January 31 2018
End Date
January 15 2019
Last Update
September 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Navipharm
Suwon, Gyeonggi-do, South Korea, 16209